Clinicopathological characteristics and MYC status determine treatment outcome in plasmablastic lymphoma: a multi-center study of 76 consecutive patients

Hanno M. Witte, Nadine Hertel, Hartmut Merz, Heinz Wolfram Bernd, Veronica Bernard, Stephanie Stölting, Nikolas von Bubnoff, Alfred C. Feller, Niklas Gebauer*

*Corresponding author for this work
Original languageEnglish
Article number63
JournalBlood Cancer Journal
Issue number5
Pages (from-to)63
Publication statusPublished - 29.05.2020

Research Areas and Centers

  • Research Area: Medical Genetics

Cite this